Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Medicare opts not to make CT radiation-related quality measure mandatory in 2027
The measure evaluates the proportion of scans that exceed certain thresholds for image noise or radiation dose across 18 categories.
Emphysema on baseline lung cancer CT a sign of future mortality risk
“Lung cancer screening shouldn’t just be looking for nodules. That’s a small part of what we see on the CT scan.”
Key trends in nuclear cardiology take center stage at ASNC 2025
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
Lantheus misled investors about blockbuster imaging agent, class action lawsuit claims
Plaintiff attorneys claim the Massachusetts-based company shattered the competitive position of Pylarify, a PET imaging agent for prostate cancer.
GE HealthCare to acquire Alzheimer’s imaging AI firm Icometrix
Founded in 2011 and based in Belgium, the AI firm offers the first software for automating brain assessments needed to administer disease therapies from Biogen and Eli Lilly.

WMIC 2013 focuses on first-in-human studies and new scientists

The 2013 World Molecular Imaging Congress (WMIC) held Sept. 18-21 in Savannah, Ga., highlighted biomarker clinical trials, diabetes and brain research, advances in technology and a program that encouraged emerging experts, say World Molecular Imaging Society leaders in an exclusive interview with Molecular Imaging.

Siemens’ PETNET Solutions to provide PET radiopharmaceutical services for the US Oncology Network

Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved PET radiopharmaceutical agents at each of PETNET Solutions’ current Good Manufacturing Practices (cGMP)-certified locations throughout the United States.

Double duty: Cancer therapy moonlights as breast tumor imaging agent

Metastatic breast cancers positive for HER2 receptor expression can be effectively imaged with Cu-64 DOTA-trastuzumab, traditionally used as a therapeutic drug, according to a study published online Sept. 12 in the Journal of Nuclear Medicine.

WMIC brings the world of molecular imaging to Georgia this week

The World Molecular Imaging Congress being held in Savannah, Ga., from September 18 – 21 is in full swing and bringing new focus to the worldwide molecular imaging agenda.

Definiens and Advanced Cell Diagnostics launch software for quantitative RNA in situ hybridization

Definiens AG, a healthcare company that advances personalized medicine through image analysis and digital pathology solutions, and Advanced Cell Diagnostics (ACD) of Hayward California, a leader in molecular pathology, announced recently the commercial launch of RNAscope® SpotStudio™, a custom-designed image analysis software application for ACD's RNAscope®Assays to detect and quantify RNA biomarkers.

VCAM-1 imaging in ovarian cancer may improve survival

Homing in on vascular cell adhesion molecule-1 (VCAM-1) expression in metastatic ovarian cancer with SPECT could gauge response to therapy and potentially improve survival, according to a study published Sept. 12 in the Journal of Nuclear Medicine.

Technetium kit shortage until mid-October

Jubilant DraxImage, a distributor of the MAA lyophilized Technetium-99m kit, announced that as of Sept. 6 a disruption in the company’s supply chain would effectively render the technetium-synthesis kit out-of-stock until an unspecified date in October, according to a letter to customers.

Choosing Wisely Adds Some Post-Op DVT Ultrasounds to List of Questionable Procedures

Avoid performing routine post-operative deep vein thrombosis (DVT) ultrasonography screening in patients who undergo elective hip or knee arthroplasty, says the American Academy of Orthopaedic Surgeons (AAOS) in its contribution to the Choosing Wisely list of frequently ordered but often unnecessary medical tests and procedures

Medical Imaging

Medicare opts not to make CT radiation-related quality measure mandatory in 2027

Emphysema on baseline lung cancer CT a sign of future mortality risk

Key trends in nuclear cardiology take center stage at ASNC 2025

Lantheus misled investors about blockbuster imaging agent, class action lawsuit claims

GE HealthCare to acquire Alzheimer’s imaging AI firm Icometrix